Literature DB >> 7780985

Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium.

S B Ho1, L L Shekels, N W Toribara, Y S Kim, C Lyftogt, D L Cherwitz, G A Niehans.   

Abstract

Mucins synthesized by malignant cells may contribute (via decreased cellular adhesion and immune recognition) to cancer invasion and metastases. Human mucins are derived from a heterogeneous family of genes, labeled MUC1-6. Our aim was to determine the pattern of mucin gene expression in normal, preneoplastic (intestinal metaplasia), and malignant gastric specimens. Probes and antibodies for specific mucin tandem repeat sequences were used for RNA and immunohistochemical analysis. Normal stomach mucosa was characterized by expression of MUC1, MUC5, and MUC6 mRNA and immunoreactive protein, without MUC2, MUC3, and MUC4 gene expression. In contrast, high levels of MUC2 and MUC3 mucin mRNA and immunoreactive protein were found in specimens with intestinal metaplasia. Gastric cancers exhibited markedly altered secretory mucin mRNA levels compared with adjacent normal mucosa, with decreased levels of MUC5 and MUC6 mRNA and increased levels of MUC3 and MUC4 mRNA. Overall, immunoreactive MUC1 mucin was detected in 72% of 33 gastric cancers, and secretory mucin core peptides were expressed in 34% (MUC2), 45% (MUC3), 19% (MUC5), and 57% (MUC6) of these specimens. Coexpression of multiple (three or more) mucin core proteins occurred in 15 of 25 (60%) advanced (stages III and IV) cancers compared with 1 of 8 (12.5%) early (stages I and II) cancers (P < 0.048). We conclude that human gastric epithelium has a unique mucin gene pattern, which becomes markedly altered in preneoplastic and neoplastic specimens. Increased mucin gene heterogeneity in gastric adenocarcinomas is associated with advanced cancer stage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7780985

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  82 in total

1.  Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.

Authors:  Henrik Nordman; Julia R Davies; Gert Lindell; Carme de Bolós; Francisco Real; Ingemar Carlstedt
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 2.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

3.  SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathological features and prognosis.

Authors:  Xin Zhang; Hao Yu; Yongtao Yang; Rong Zhu; Jianying Bai; Zhihong Peng; Yonghong He; Lei Chen; Wensheng Chen; Dianchun Fang; Xiuwu Bian; Rongquan Wang
Journal:  J Gastrointest Surg       Date:  2010-06-08       Impact factor: 3.452

4.  Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia.

Authors:  Tetsuya Tsukamoto; Kenichi Inada; Harunari Tanaka; Tsutomu Mizoshita; Mami Mihara; Toshikazu Ushijima; Yoshitaka Yamamura; Shigeo Nakamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-12-04       Impact factor: 4.553

Review 5.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

Review 6.  Prognostic value of Muc5AC in gastric cancer: A meta-analysis.

Authors:  Chuan-Tao Zhang; Ke-Cheng He; Fei Pan; Yuan Li; Jiang Wu
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

7.  Expression of MUC2 gene in gastric regenerative, metaplastic, and neoplastic epithelia.

Authors:  M Mitsuuchi; Y Hinoda; F Itoh; T Endo; M Satoh; P X Xing; K Imai
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 8.  Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis.

Authors:  Yoshio Yamaoka
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 9.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

10.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Hayao Nakanishi; Ken-ichi Inada; Naotaka Ogasawara; Takashi Joh; Makoto Itoh; Yoshitaka Yamamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.